Methylfolate
L-5-methyltetrahydrofolate (5-MTHF)
Evidence: Strong
Folate is essential wherever cells divide quickly, and nowhere divides faster than the lining of your gut, which renews itself every few days. Folate has a role in the process of cell division and contributes to normal amino acid synthesis and to normal blood formation, the kind of foundational housekeeping that fast-renewing tissues like the intestinal wall rely on.
We use methylfolate (L-5-MTHF), the active form the body can use directly. This matters because a large share of people carry common genetic variations that make converting ordinary folic acid less efficient. By supplying folate already in its active form, we sidestep that bottleneck, so the nutrient is ready to work regardless of genetics.
PubMed indexes over 76,000 peer-reviewed papers on folate.
Selected study 1 of 2
Carboni L. Active Folate Versus Folic Acid: The Role of 5-MTHF (Methylfolate) in Human Health. Integrative Medicine: A Clinician's Journal. 2022;21(3):36-41.
Study summary
Study type: 2022 narrative review comparing folic acid with active 5-MTHF.
Observed benefits:
- 5-MTHF is absorbed efficiently and does not leave unmetabolised folic acid in the blood.
- It supports normal homocysteine metabolism regardless of MTHFR genotype.
Mechanisms: 5-MTHF arrives pre-activated, so it enters one-carbon metabolism directly without relying on the rate-limiting conversion enzymes.
Safety: No adverse events noted at typical supplemental doses.
Evidence strength: Strong mechanistic basis with supportive small trials; large independent outcome trials still limited.
Selected study 2 of 2
Tate C, Shuman A, Nice S, Salehi P. The Critical Role of Folate in Prenatal Health and a Proposed Shift from Folic Acid to 5-Methyltetrahydrofolate Supplementation. Georgetown Medical Review. 2024;8(1). doi:10.52504/001c.124570
Study summary
Study type: 2024 narrative review of prenatal folate.
Observed benefits: Adequate folate supports healthy maternal and fetal development; 5-MTHF offers reliable bioavailability regardless of enzyme activity and avoids build-up of unmetabolised folic acid.
Mechanisms: Only the active form can directly donate the methyl group used in one-carbon metabolism, bypassing the conversion bottleneck.
Safety: Physiological doses of either form are generally safe.
Evidence strength: Sound biochemical rationale; direct head-to-head pregnancy outcome trials still lacking.